---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-267472"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2026-06-11T20:02:14+00:00"
generated_at: "2026-06-11T20:03:09.750853+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.12
calibrated_materiality_score: 0.12
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology shareholders elect directors, approve executive compensation and auditor at annual meeting

## Summary
- Vote results: Daniel Curran (100.9M for), Rekha Hemrajani (82.7M for), Chris Takimoto (100.9M for) elected to Class II board.
- Say-on-pay advisory vote passed: 84.5M for, 13.5M against, 2.9M abstain.
- KPMG LLP ratified as independent auditor for FY2026: 119.3M for, 1.8K against, 9.3K abstain.
- All director nominees elected; significant withheld votes for Hemrajani (18.3M) but still elected.

## SEC filing metadata
- accession: 0001193125-26-267472
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2026-06-11T20:02:14+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.12
- calibrated_materiality_score: 0.12
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/alxo-20260610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-267472
- JSON: https://secwatch.observer/filing/0001193125-26-267472.json
- Plain text: https://secwatch.observer/filing/0001193125-26-267472.txt

## Key facts
- Shareholder Votes
  ALX ONCOLOGY HOLDINGS INC shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: Proposal 3: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain 119,293,775 1,797 9,292
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm
- Shareholder Votes
  ALX ONCOLOGY HOLDINGS INC shareholders approved Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2026-06-10 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: Proposal 2: Advisory Vote on the Compensation of the Company’s Named Executive Officers For Against Abstain Broker Non-Votes 84,540,061 13,497,711 2,953,259 18,313,833
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm
- Shareholder Votes
  ALX ONCOLOGY HOLDINGS INC shareholders approved Election of Two Class II Directors at the 2026-06-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: Proposal 1: Election of Two Class II Directors Name of Director For Withheld Broker Non-Votes Daniel Curran, M.D. 100,933,233 57,798 18,313,833 Rekha Hemrajani 82,732,430 18,258,601 18,313,833 Chris Takimoto, M.D., Ph.D., F.A.C.P. 100,946,696 44,335 18,313,833
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810182/000119312526267472/0001193125-26-267472-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.